What is Mayflower Bioscience?
Mayflower Bioscience is a St. Louis, MO-based entity dedicated to providing innovative solutions for drug discovery, cell biology, and molecular biology. The company offers a comprehensive portfolio of high-quality products, including antibodies, bioassays, and COVID-19 testing kits, designed to empower researchers in their scientific pursuits. Serving clients across the US and Canada, Mayflower Bioscience emphasizes US-based technical support and customer service, aiming to enhance research and development initiatives through unique product sourcing and delivery.
How much funding has Mayflower Bioscience raised?
Mayflower Bioscience has raised a total of $732K across 1 funding round:
Debt
$732K
Debt (2024): $732K with participation from St Louis Bank
Key Investors in Mayflower Bioscience
St Louis Bank
St Louis Bank is a financial institution likely providing debt financing, supporting Mayflower Bioscience's operational and growth capital needs.
What's next for Mayflower Bioscience?
The recent major strategic investment signals a period of accelerated growth and expansion for Mayflower Bioscience. This capital infusion is expected to fuel further innovation in their product offerings and potentially broaden their market reach within the life sciences sector. The company's focus on supporting critical research areas positions it for continued development and impact in the competitive landscape of biotechnology and pharmaceutical research.
See full Mayflower Bioscience company page
